Random-effects linear modeling and sample size tables for two special crossover designs of average bioequivalence studies: the four-period, two-sequence, two-formulation and six-period, three-sequence, three-formulation designs.
about
Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical Trial.Measuring the individual benefit of a medical or behavioral treatment using generalized linear mixed-effects models.Estimating individual benefits of medical or behavioral treatments in severely ill patients.
P2860
Random-effects linear modeling and sample size tables for two special crossover designs of average bioequivalence studies: the four-period, two-sequence, two-formulation and six-period, three-sequence, three-formulation designs.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Random-effects linear modeling ...... ce, three-formulation designs.
@en
Random-effects linear modeling ...... ce, three-formulation designs.
@nl
type
label
Random-effects linear modeling ...... ce, three-formulation designs.
@en
Random-effects linear modeling ...... ce, three-formulation designs.
@nl
prefLabel
Random-effects linear modeling ...... ce, three-formulation designs.
@en
Random-effects linear modeling ...... ce, three-formulation designs.
@nl
P2093
P2860
P1476
Random-effects linear modeling ...... ce, three-formulation designs.
@en
P2093
Barry E Gidal
Francisco J Diaz
Michael Privitera
Michel J Berg
Rita Alloway
Ron Krebill
Timothy Welty
P2860
P2888
P304
P356
10.1007/S40262-013-0103-4
P577
2013-12-01T00:00:00Z
P5875
P6179
1038659353